| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2000 | WO2000048590A1 Substituted stilbene compounds with vascular damaging activity |
| 08/24/2000 | WO2000048589A1 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier |
| 08/24/2000 | WO2000048588A1 Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug |
| 08/24/2000 | WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma |
| 08/24/2000 | WO2000048586A1 Remedies |
| 08/24/2000 | WO2000048585A1 Effervescent laxatives |
| 08/24/2000 | WO2000048584A2 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| 08/24/2000 | WO2000048583A2 Formulation of 5-ht agonists with nsaids, especially cox-2 inhibitors, for treating migraine |
| 08/24/2000 | WO2000048582A2 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence |
| 08/24/2000 | WO2000048581A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 08/24/2000 | WO2000048579A1 Desoxypeganine transdermal therapeutic system |
| 08/24/2000 | WO2000048577A1 Medicament for the treatment and prevention of cancer of the intestine |
| 08/24/2000 | WO2000048572A1 Phosphocholine linked prodrug derivatives |
| 08/24/2000 | WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 08/24/2000 | WO2000048570A1 Pharmaceutical composition for balanic transmucosal administration of alfuzosin |
| 08/24/2000 | WO2000048567A1 Method and composition for treating acne |
| 08/24/2000 | WO2000048566A1 Skin preparations for external use |
| 08/24/2000 | WO2000048559A2 Composition for promoting hair growth comprising derivatives of vitamins and dmso |
| 08/24/2000 | WO2000048556A1 Mono and dialkyl quats with silicone in conditioning compositions |
| 08/24/2000 | WO2000048554A2 Synergistic antimicrobial skin washing compositions |
| 08/24/2000 | WO2000048551A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 08/24/2000 | WO2000048549A2 Anticonvulsant derivatives useful in treating essential tremor |
| 08/24/2000 | WO2000048463A1 Method for preparation of pharmaceutical-grade dithiocarbamate |
| 08/24/2000 | WO2000048447A2 Composition for treatment of external secretion disorders except hypolacrimation |
| 08/24/2000 | WO2000048446A2 Use of antagonists of pg-e for the treatment of neuropathic pain |
| 08/24/2000 | WO2000048445A2 Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence |
| 08/24/2000 | WO2000037470A8 Antihistaminic spiro compounds |
| 08/24/2000 | WO2000032205A8 Immunomodulatory methods using carbohydrate antigens |
| 08/24/2000 | WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 08/24/2000 | WO2000027380A3 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 08/24/2000 | WO2000024362A3 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use |
| 08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/24/2000 | WO2000023056A3 The use of dopaminergic agents in the management of sexual dysfunction |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000021513A3 Methods for treating multiple sclerosis |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000018394A9 Adrenoleukodystrophy treatments and drug screening |
| 08/24/2000 | WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/24/2000 | WO2000015205A3 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes |
| 08/24/2000 | WO2000013654A3 A carotenoid composition containing phytoene and phytofluene |
| 08/24/2000 | WO2000012685A3 Genes associated with neurotransmitter processing |
| 08/24/2000 | WO2000012623A3 Use of 5-th receptor antagonists for the treatment of parkinson's disease |
| 08/24/2000 | WO2000010611A3 Drug targeting |
| 08/24/2000 | WO2000010536A9 Extended release buccal bioadhesive tablet |
| 08/24/2000 | WO2000009100A3 Benzothiepine compounds as enhancer of cell differentiation induction factor |
| 08/24/2000 | WO2000002593A3 Cleansing and treating lotion for treating comedones |
| 08/24/2000 | WO1999067379A3 Structured antisense nucleic acid molecules |
| 08/24/2000 | WO1999066900A3 Use of nonoxynol-9 as lubricant and method for its production |
| 08/24/2000 | WO1999042828A3 Treating cancer |
| 08/24/2000 | WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 08/24/2000 | WO1996012697A9 Calcium receptor-active compounds |
| 08/24/2000 | DE19907385A1 New 3-(phenoxy or phenylalkoxy)-2-phenyl-propylamines, useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases, are tension-dependent sodium channel blockers |
| 08/24/2000 | DE19906978A1 Treating drug dependence and/or addiction, e.g. due to cocaine or heroin, using desoxypeganine as choline esterase inhibitor and monoamine oxidase inhibitor which crosses blood-brain barrier |
| 08/24/2000 | DE19906975A1 Treating Alzheimer's dementia, especially by improving cognitive ability, using desoxypeganine as choline esterase inhibitor and monoamine oxidase inhibitor |
| 08/24/2000 | DE19859771C1 Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung Water-soluble, stable pyruvic acid (salts) -containing formulation |
| 08/24/2000 | CA2541869A1 Compositions and methods for use in targeting vascular destruction |
| 08/24/2000 | CA2455956A1 Compositions and methods for use in targeting vascular destruction |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2371824A1 .beta.-alanine derivatives |
| 08/24/2000 | CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma |
| 08/24/2000 | CA2363695A1 Dopamine d1 receptor agonist compounds |
| 08/24/2000 | CA2363670A1 Chemical compounds |
| 08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | CA2362943A1 Pyk2 binding proteins |
| 08/24/2000 | CA2362862A1 Bicyclic compounds and their use as integrin receptor ligands |
| 08/24/2000 | CA2362787A1 Novel redox clamping agents and uses thereof |
| 08/24/2000 | CA2362355A1 Effervescent laxatives |
| 08/24/2000 | CA2362346A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 08/24/2000 | CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists |
| 08/24/2000 | CA2362306A1 Chemical compounds |
| 08/24/2000 | CA2362303A1 Growth hormone secretagogues |
| 08/24/2000 | CA2362290A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | CA2362288A1 Use of lipoic acid combination with ascorbic acid in the treatment of cancer |
| 08/24/2000 | CA2362267A1 Mono and dialkyl quats with silicone in conditioning compositions |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2362166A1 Method for preparation of pharmaceutical-grade dithiocarbamate |
| 08/24/2000 | CA2362071A1 Method for screening compound having affinity for vitamin d receptor |
| 08/24/2000 | CA2361390A1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| 08/24/2000 | CA2361278A1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
| 08/24/2000 | CA2360353A1 2-amino-6-anilino-purines and their use as medicaments |
| 08/24/2000 | CA2329524A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 08/24/2000 | CA2328877A1 Composition for treatment of external secretion disorders except hypolacrimation |
| 08/24/2000 | CA2299117A1 Antimycotic compositions |
| 08/23/2000 | EP1029921A1 Serpin resistant chymotrpsin superfamily proteases, particularly PAI-1 resistant t-PA, complementary inhibitor mutants; compositions; genes; expressions |
| 08/23/2000 | EP1029872A1 Piperazine-cyclodextrin complexes |
| 08/23/2000 | EP1029868A1 Hysteromyoma remedy containing dienogest as the active ingredient |
| 08/23/2000 | EP1029865A2 Process and intermediates for preparing 5-lipoxygenase inhibitors |
| 08/23/2000 | EP1029863A1 Novel camptothecin derivatives |
| 08/23/2000 | EP1029861A1 Benzisothiazol-piperazinyl derivative and its use as neuroleptic |
| 08/23/2000 | EP1029859A1 N,N'-Disubstituted unsymmetrical cyclic urea and its use in therapy |
| 08/23/2000 | EP1029854A1 Oxazolidinones and their use as antibacterial agents |
| 08/23/2000 | EP1029853A1 Heteroaromatic bicyclic derivatives useful as anticancer agents |
| 08/23/2000 | EP1029851A1 Piperazine compounds and medicinal use thereof |
| 08/23/2000 | EP1029551A2 Nitrogen monoxide metabolite-polyoxyalkylene-hemoglobin complex |
| 08/23/2000 | EP1029544A1 Intra-cancer-cell nuclease activator |
| 08/23/2000 | EP1029543A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 08/23/2000 | EP1029542A1 Percutaneously absorbable preparation |
| 08/23/2000 | EP1029541A1 Therapeutic or prophylactic agent for glomerulopathy |
| 08/23/2000 | EP1029540A2 Use of droloxifene for the treatment of cardiovascular diseases |
| 08/23/2000 | EP1029538A2 Soft gelatin capsule manufacture |